Research programme: T-cell receptor natural killer cell therapies - Syena
Alternative Names: TCR-NK cell therapies - SyenaLatest Information Update: 08 Mar 2023
Price :
$50 *
At a glance
- Originator Syena
- Class Antineoplastics; Gene therapies; Immunotherapies; Natural killer cell therapies
- Mechanism of Action Immunologic cytotoxicity; Natural killer cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Haematological malignancies; Solid tumours